# Exception from Informed Consent Requirements for Emergency Research:  Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/exception-from-informed-consent-requirements-for-emergency-research-guidance-for-institutional-review-boards-clinical-investigators-and-sponsors/c1c4c389-82e0-4459-b587-78c877667c9b

> FDA guidance document: Exception from Informed Consent Requirements for Emergency Research:  Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors. Issue date: April 01, 2013. Get complete insights and analysis.

---

## Details

- Title: Exception from Informed Consent Requirements for Emergency Research:  Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors
- Communication Type: Guidance Document
- Product Type: devices
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2013-04-01
- Last Changed: 2025-02-03
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2006-D-0464">FDA-2006-D-0464</a>

## Related Documents

- [Financial Disclosure by Clinical Investigators:  Guidance for Clinical Investigators, Industry,and FDA Staff](https://www.globalkeysolutions.net/guidances/guidance-document/financial-disclosure-by-clinical-investigators-guidance-for-clinical-investigators-industryand-fda-staff/a2fdcaf8-673b-4e11-9017-f37e4d719af8)
- [Considerations When Transferring Clinical Investigation Oversight to Another IRB:  Guidance for IRBs, Clinical Investigators, and Sponsors](https://www.globalkeysolutions.net/guidances/guidance-document/considerations-when-transferring-clinical-investigation-oversight-to-another-irb-guidance-for-irbs-clinical-investigators-and-sponsors/fe8296e5-3ca7-4209-9920-27aa4635ee35)
- [IRB Continuing Review After Clinical Investigation Approval:  Guidance for IRBs, Clinical Investigators, and Sponsors](https://www.globalkeysolutions.net/guidances/guidance-document/irb-continuing-review-after-clinical-investigation-approval-guidance-for-irbs-clinical-investigators-and-sponsors/7c18de8c-1544-4b72-a67a-3a861d29c31c)